Ineos Unveils Major Expansion Plans in Europe
Ineos has announced plans to build a new European petrochemical production plant and boost capacity at plants in Scotland and Norway at a cost of about two billion euros (£1.8bn).
The plans include a new propylene production unit, with sites in Belgium among locations being considered.
It also plans to increase the ethylene capacity of its crackers at Grangemouth in Scotland and Rafnes in Norway.
Both rely on fracked shale gas being shipped across to Europe from the US.
Ethylene and propylene are key building blocks in the manufacture of plastics.
In a statement, Ineos said its investment would boost the amount of ethylene it can produce at each plant in Grangemouth and Rafnes by about 50%, to more than one million tonnes.
About 150 new jobs are expected to be created at each location, once the expansion of processing units is completed in three to four years' time.
Gerd Franken, from Ineos, said: "These expansions and new-builds will increase our self-sufficiency in all key olefin products and give further support to our derivative businesses and polymer plants in Europe.
"All our assets will benefit from our capability to import competitive raw materials from the US and the rest of the world."
2026-09-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
INEOS Shuts Down Europe's Last World-Scale Acetyl Production Facilities
-
Ineos Rescues UK's Last Dichloroethane Plant
-
Ineos Exits Sinopec Tianjin Joint Venture, Pays $120 Million "Breakup Fee"
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
Ineos Invests £30m to Reduce Emissions at Hull Site by 75%
-
Vitafoods Europe lights up Barcelona with record-breaking 2025 event
-
INEOS Sells Its Health Care Business to SKG Capital Partners
-
INEOS and Covestro Sign Major Long-Term Gas Supply Agreement
-
INEOS Completes Sale of Composites Business for €1.7 billion
Recommend Reading
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
McKinsey Pays to Close a Purdue Liability Chapter
-
BASF Raises Acid Chloride and Chloroformate Capacity by 30% at Ludwigshafen
-
Business Society September 21, 2026 MTBE Trend Analysis: Weak Rebound
-
Business Society September 21, 2026 Petroleum Coke Trend Analysis: Rising
-
Geopolitical Risks Ease, Oil Prices Plunge to Multi-Week Lows
-
Business Society September 22, 2026 Methanol Trend Analysis: Clear Downtrend
-
Business Society September 22, 2026 Phenol Trend Analysis: Weakly Tending